Cresco Labs (OTCMKTS:CRLBF) Trading Down 0.1% – Should You Sell?

Cresco Labs Inc. (OTCMKTS:CRLBF) was down 0.1% during mid-day trading on Thursday . The stock traded as low as $0.7170 and last traded at $0.7291. 280,673 shares were traded during mid-day trading, a decline of 52% from the average daily volume of 581,200 shares. The stock had previously closed at $0.73.

Analyst Upgrades and Downgrades

Separately, Alliance Global Partners reiterated a “buy” rating on shares of Cresco Labs in a research report on Thursday, August 6th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Buy”.

Cresco Labs Price Performance

The firm has a market capitalization of $366.56 million, a price-to-earnings ratio of -2.43 and a beta of 1.57. The company has a fifty day moving average price of $0.74 and a two-hundred day moving average price of $0.86. The company has a quick ratio of 0.98, a current ratio of 1.78 and a debt-to-equity ratio of 1.66.

Cresco Labs (OTCMKTS:CRLBF) last announced its earnings results on Thursday, August 6th. The company reported $0.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.06. The business had revenue of $173.34 million for the quarter, compared to analyst estimates of $166.20 million. Cresco Labs had a negative net margin of 15.50% and a negative return on equity of 7.53%. On average, equities research analysts expect that Cresco Labs Inc. will post -0.04 EPS for the current fiscal year.

About Cresco Labs

Cresco Labs Inc is a vertically integrated cannabis company that cultivates, manufactures, distributes and sells cannabis products in the United States. Its operations include cannabis cultivation facilities, product manufacturing and wholesale distribution, as well as retail dispensaries operating under the Sunnyside brand.

The company offers a range of cannabis products, including flower, pre-rolls, vapes, concentrates, edibles and other wellness-oriented products. Its portfolio has included brands such as Cresco, High Supply, Good News, Wonder Wellness, Remedi and FloraCal Farms, with product availability varying by state and local regulations.

Founded in 2013 and headquartered in Chicago, Cresco Labs serves regulated cannabis markets through state-licensed operations.